Cytokines and cytokine therapies in HIV infection, AIDS Clin Rev, pp.187-228, 1997. ,
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection, J Virol, vol.68, issue.9, pp.6103-6113, 1994. ,
Acute human immunodeficiency virus type 1 infection, N Engl J Med, vol.339, issue.1, pp.33-42, 1998. ,
Acute HIV-1 infection, N Engl J Med, vol.364, issue.20, pp.1943-54, 2011. ,
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load, Blood, vol.104, issue.4, pp.942-949, 2004. ,
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy, J Infect Dis, vol.187, issue.10, pp.1534-1577, 2003. ,
Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384, Clin Infect Dis, vol.48, issue.3, pp.350-61, 2009. ,
Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation, J Exp Med, vol.192, issue.2, pp.295-302, 2000. ,
Mechanisms of suppression by suppressor T cells, Nat Immu nol, vol.6, issue.4, pp.338-382, 2005. ,
Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy, PLoS One, vol.5, issue.7, p.11659, 2010. ,
Level of double negative T cells, which produce TGF-? and IL-10, predicts CD8 T-cell activation in primary HIV-1 infection, AIDS, vol.26, issue.2, pp.139-187, 2012. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02006421
Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells, J Infect Dis, vol.211, issue.5, pp.769-79, 2015. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02573709
CD4-like immunological function by CD4-T cells in multiple natural hosts of simian immunodeficiency virus, J Virol, vol.85, issue.17, pp.8702-8710, 2011. ,
Multifunctional double-negative T cells in sooty mangabeys mediate T-helper functions irrespective of SIV infection, PLoS Pathog, vol.9, issue.6, p.1003441, 2013. ,
Defining the nature of human ?? T cells: a biographical sketch of the highly empathetic, Cell Mol Immunol, vol.10, issue.1, pp.21-30, 2013. ,
The multifunctionality of human V?9V?2 ?? T cells: clonal plasticity or distinct subsets?, Scand J Immunol, vol.76, issue.3, pp.213-235, 2012. ,
Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity, Nat Rev Immunol, issue.7, pp.467-78, 2010. ,
?? T Lymphocytes as a first line of immune defense: old and new ways of antigen recognition and implications for cancer immunotherapy, Front Immunol, vol.5, p.575, 2014. ,
CDR3-independent gamma delta V delta 1+ T cell expansion in the peripheral blood of HIV-infected persons, J Immunol, vol.154, issue.3, pp.1418-1449, 1995. ,
Peripheral V gamma 9/V delta 2 T cell deletion and anergy to nonpeptidic mycobacterial antigens in asymptomatic HIV-1-infected persons, J Immunol, vol.157, issue.1, pp.449-61, 1996. ,
HIV envelope-mediated, CCR5/?4?7-dependent killing of CD4-negative ?? T cells which are lost during progression to AIDS, Blood, vol.118, issue.22, pp.5824-5855, 2011. ,
Phenotypic analysis of peripheral blood gammadelta T lymphocytes and their targeting by human immunodeficiency virus type 1 in vivo, Virology, vol.305, issue.2, pp.415-442, 2003. ,
Peripheral V?9V?2 T cells are a novel reservoir of latent HIV infection, PLoS Pathog, vol.11, issue.10, p.1005201, 2015. ,
Distortion of memory V?2 ?? T cells contributes to immune dysfunction in chronic HIV infection, Cell Mol Immunol, vol.12, issue.5, pp.604-618, 2015. ,
Primary and chronic HIV infection differently modulates mucosal V?1 and V?2 T-cells differentiation profile and effector functions, PLoS One, vol.10, issue.6, p.129771, 2015. ,
Tumorderived ?? regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence, J Immunol, vol.190, issue.5, pp.2403-2417, 2013. ,
Human peripheral gammadelta T cells possess regulatory potential, Immunology, vol.128, issue.4, pp.580-588, 2009. ,
Phenotype and regulation of immunosuppressive V?2-expressing ?? T cells, Cell Mol Life Sci, vol.71, issue.10, pp.1943-60, 2014. ,
??-T cells: an unpolished sword in human anti-infection immunity, Cell Mol Immunol, vol.10, issue.1, pp.50-57, 2013. ,
Differential impact of age and cytomegalovirus infection on the ?? T cell compartment, J Immunol, vol.191, issue.3, pp.1300-1306, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02455351
Longterm expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection, Blood, vol.112, issue.4, pp.1317-1341, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00356753
Potential regulatory role of in vitro-expanded V?1 T cells from human peripheral blood, Immunol Res, vol.56, issue.1, pp.172-80, 2013. ,
The significance of interferon-? in HIV-1 pathogenesis, therapy, and prophylaxis, Front Immunol, vol.4, p.498, 2014. ,
Transforming growth factor-beta regulation of immune responses, Annu Rev Immunol, vol.24, pp.99-146, 2006. ,
The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation, PLoS Pathog, vol.9, issue.6, p.1003453, 2013. ,
CD4 T-cell responses in primary HIV infection: interrelationship with immune activation and virus burden, Front Immunol, vol.7, p.395, 2016. ,
Immunosuppressive tryptophan catabolism and gut mucosal dysfunction following early HIV infection, J Infect Dis, vol.212, issue.3, pp.355-66, 2015. ,
Persistent, albeit reduced, chronic inflammation in persons starting antiretroviral therapy in acute HIV infection, Clin Infect Dis, vol.64, issue.2, pp.124-155, 2017. ,
?? T cells in HIV disease: past, present, and future, Front Immunol, vol.5, p.687, 2014. ,
Risk factors and outcomes for late presentation for HIV-positive ,